Regarding the recall alert for HAUPT PHARMA AMAREG GMBH drug Litalir 500mg (batch numbers 4L9808, 4D8922), no such batch of drug has been imported into the country.

Dabrafenib is a BRAF inhibitor cancer drug, available as a mesylate. On May 29, 2013, the U.S. Food and Drug Administration (FDA) simultaneously approved the marketing applications of dabrafenib and trametinib. Dabrafenib is approved for the treatment of unresectable melanoma (tumors that cannot be surgically removed) and metastatic melanoma (tumors that have spread to other organs) harboring the BRAF V6 Chemicalbook00E mutation, but not for the treatment of wild-type BRAF melanoma. Mekinist is used to treat BRAF V600E or V600...